Transdifferentiation of cells from a patient's own liver into pancreatic b-cells could be useful for b-cell replacement. We hypothesized that intrahepatic biliary epithelial cells (IHBECs) could become a new source of insulin-producing cells. IHBECs isolated from adult mice were expanded using our novel culture method termed, collagen-embedded floating culture method (CEFCM). With CEFCM, IHBECs formed three-dimensional ductal cysts and rapidly expanded their number by about 15-fold within 2 weeks. Over 90% of cells were positive for cytokeratin 7 and 19. At day 14, IHBECs were transfected with adenoviral (Ad)-pancreas duodenum homeobox 1 (Pdx-1), NeuroD or Pdx-1/VP16. After 7 additional days in serum-and insulin-free differentiation medium (DM), cell phenotypes were determined by RT-PCR, immunostaining and ELISA for insulin. In DM control IHBECs started to express some endocrine progenitor genes (Neurog3, NeuroD, Nkx6.1, and Pdx-1) but lacked insulin gene (Ins) mRNA. Transduced expression of PDX-1, NEUROD or PDX-1/VP16 led to expression of not only INS but also GLUT2 and prohormone convertase 1 and 2. About 3% of 4000 cells counted in PDX-1/VP16 transduced cultures stained strongly for C-peptide suggesting that a subpopulation may have the capacity for differentiation.
Introduction
There is great hope that transplantation of insulin-producing cells will be a cure-equivalent for type 1 diabetes (Shapiro et al. 2000 , Ricordi & Strom 2004 ), however, two major challenges remain: the shortage of available tissue and the need for immunosuppressive drugs. To resolve the first problem, efforts are underway to produce sufficient quantities of b-cells for transplantation (Bonner-Weir & Weir 2005) . Promising strategies include differentiation of embryonic stem cells (Kroon et al. 2008) , conversion of either pancreatic adult stem/progenitor cells (Bonner-Weir et al. 2000) , expansion of existing b-cells (Gershengorn et al. 2004) , and xenotransplantation (Cardona et al. 2006 , Hering et al. 2006 . Transdifferentiation of cells from a patient's own tissue into pancreatic b-cells could address one obstacle of islet transplantation. This tissue could be obtained from a diabetic individual by endoscopic surgery, followed by in vitro expansion and differentiation into insulin-producing cells for subsequent autologous transplantation. Some researchers have pursued transdifferentiation using liver tissue both in vivo and in vitro (Ferber et al. 2000 , Yang et al. 2002 , Kojima et al. 2003 , Sapir et al. 2005 , Zalzman et al. 2005 , Tang et al. 2006 . The advantage of the liver is that both liver and pancreas develop embryologically from very similar pathways via the foregut endoderm (Wilson et al. 2003 , Lemaigre & Zaret 2004 , Zaret 2008 . Ectopic expression of NEUROD and PDX-1 has been found to promote the differentiation of liver towards pancreas (Ferber et al. 2000 , Kojima et al. 2003 , Sapir et al. 2005 , Zalzman et al. 2005 . Among the cell populations in the liver, the bile duct epithelium seems to have considerable promise as a new source of insulin-producing cells. It is clear that b-cells can exist surrounding the common bile duct of the liver (Sumazaki et al. 2004 , Dutton et al. 2007 , but the use of extrahepatic duct cells is problematic because the removal of sufficient amounts of tissue would be very dangerous (Antolovic et al. 2007) . Oval cells are considered to be transit-amplifying hepatic progenitor cells (Factor et al. 1994 , Yang et al. 2002 , Kofman et al. 2005 and it has also been suggested that they can be precursors of insulin producing cells (Yang et al. 2002) . However, they only appear in response to several types of pathologic liver injury (Factor et al. 1994 , Kofman et al. 2005 .
We focused our attention on intrahepatic biliary epithelial cells (IHBECs) for the following reasons: 1) A considerable amount of liver tissue can be surgically removed without much difficulty. 2) Liver has considerable capacity for regeneration (Michalopoulos & DeFrances 1997) . 3) IHBECs can serve as progenitors in response to certain stimuli; this can be shown in biliary ductules and even in the normal liver . We used normal liver for this study; therefore, there is little chance that oval cells were included in the preparation.
Cells were transduced with adenoviruses (Ad) expressing the transcription factors pancreas duodenum homeobox 1 (PDX-1), NEUROD, or PDX-1/VP16. PDX-1 plays a crucial role in pancreatic development ( Jonsson et al. 1994 ), ß-cell differentiation (Ferber et al. 2000 , Sapir et al. 2005 , Zalzman et al. 2005 , Noguchi et al. 2006 , and the maintenance of normal ß-cell function (Ahlgren et al. 1998) . PDX-1 overexpression in pancreatic ductal cells (Noguchi et al. 2006) or the liver (Ferber et al. 2000 , Sapir et al. 2005 , Zalzman et al. 2005 , has been found to promote insulin gene expression. NEUROD is important for regulating insulin gene transcription and for the terminal differentiation of islet cells (Chae et al. 2004) . In NeuroD gene targeting experiments, the combination of NeuroD and betacellulin selectively induced islet related genes in the liver (Kojima et al. 2003) . PDX-1/VP16, a fusion protein of PDX-1 and the activating domain of the viral VP16 transcription factor, can markedly increase insulin biosynthesis and induce various pancreas-related markers in the liver and ameliorate glucose tolerance of streptozotocininduced diabetic mice (Kaneto et al. 2005) .
Herein, we demonstrated that a meaningful amount of transdifferentiation has taken place from IHBECs through the use of these transcriptional factors. The cells can express proteins characteristic of b-cells and secrete insulin.
Materials and Methods

Animals and surgery
Adult 8 week old male C57/BL6 mice were obtained from Taconic Farms (Germantown, NY, USA). All animals were bred and maintained under specific pathogen-free conditions. Joslin Diabetes Center housing and husbandry guidelines were adapted from requirements in the Animal Welfare Act and the Guide for the Care and Use of Laboratory Animals in accordance with National Institutes of Health guidelines.
Isolation and culture of IHBECs
To isolate the IHBECs, a two-step liver perfusion was performed . The perfused liver was removed and hepatocytes were selectively removed by forcing them with gentle pressure through an incision in the liver capsule. Then, the remnant containing the intact biliary tree was shaken in the flask with Hanks solution for 5 min and washed several times. This treatment serves to remove residual hepatic parenchymal cells from biliary tissue fragments. The remnant tissues were collected and minced, transferred into a flask, and then treated with 0 . 02% soybean trypsin inhibitor (Gibco, Invitrogen Corporation) and 0 . 04% collagenase solution (collagenase D, Roche) for 7 min. The digested tissues were suspended in DMEM (Gibco) with 10% FBS and 100 mg/l penicillin and 100 mg/l streptomycin, and centrifuged at 150 g for 1 . 5 min. The pellet was resuspended in the medium, filtered sequentially through 250, 100, 40 mm nylon mesh; small cell aggregates on the 40 mm mesh were retrieved. Essentially, pure isolate of biliary tissue were obtained. Typical recovery was 1!10 5 viable cells with essentially pure biliary tissue obtained.
Collagen-embedded floating culture method
Cells were suspended in DMEM/F12 (Gibco) on ice containing 0 . 3 mg/ml collagen (Collagen type I rat tail, Becton Dickenson (BD), Franklin Lakes, NJ, USA). Then 1 . 0!10 4 cells/ml per well were plated in 12-well dishes. The collagen-containing aggregates were allowed to solidify at 37 8C for 2 h; media was then changed to DMEM/F12 supplemented with 5% FBS, 5% NuSerum IV (BD), 0 . 5 mg/ml insulin-transferrin-sodium selenite (Gibco), 10 mmol/l nicotinamide, 1 mmol/l ascorbic acid 2-phosphate, 10 K7 M dexamethasone (Sigma-Aldrich Corp.), 10 ng/ml EGF (Fitzgerald Industries International, Inc., Concord, MA, USA), 10 ng/ml HGF (R&D, Minneapolis, MN, USA) 4 mg/ml forskolin (Calbiochem, San Diego, CA, USA), and 3 . 4 mg/ml 3,3,5-triiodo-L-thyromine (Calbiochem). This medium is a modification of that described by Alpini et al. (2003) , which we term growth medium (GM); it was changed every 2 days. With culture, the collagen gel (CG) containing the aggregates gradually contracted as shown in Fig. 2 .
Monolayer culture for IHBECs
After 14 days in collagen-embedded floating culture method (CEFCM) culture, the aggregates were washed in Ca 2C -free HEPES-buffered saline, then a 0 . 1% collagenase solution, for 10 min to dissolve the CG and release the aggregated IHBECs fragments. The dispersed cells were counted on the hemocytometer with trypan blue and allowed to settle, then resuspended in GM, and plated onto collagen-coated, 35 mm plastic dishes (BD) or 12-well dishes (BD) and maintained at 37 8C in a humidified 5% CO 2 incubator. After 3 days in GM, the media was changed to serum-and insulin-free differentiation medium (DM), which consisted of DMEM/F12 (Gibco) supplemented with 10 mM nicotinamide (Sigma), 1 mM ascorbic acid 2-phosphate (Sigma), 10 mM MEM Vitamin Solution (Gibco), 10 mM MEM non-essential amino acids solution, 10 mM GlutaMA-I Supplement (Gibco), 4 mg/ml transferrin (Invirogen), 10 ng/ml betacellulin (R&D), 10 ng/ml IGF-I (R&D), and 50 ng/ml exendin-4 (Sigma). The IHBECs were cultured for an additional 2 days and randomly divided into three groups; the cells were maintained in this condition (Group 1), transduced with Ad expressing -green fluorescent protein (GFP; Group 2), or transduced with Ad expressing -Pdx-1, -Neurogenin 3 (NEUROG3), -NeuroD, -Pax 4, and -Pdx-1/VP16 (Group 3). The media were changed every 2 days.
Preparation of recombinant adenoviruses
Recombinant Ad expressing Pdx-1, -Neurog3, -NeuroD, and -Pdx-1/VP16 driven by a cytomegalovirus (CMV) promoter were prepared with the AdEasy system as previously described (Kaneto et al. 2005) . These AdVs all carried the reporter GFP. The control Ad (Ad-GFP) was prepared in the same manner. Ad expressing Pax4 (Ad-Pax4) was kindly provided by Dr St-Onge (DeveloGen AG, Gottingen, Germany) and contains the construct of CMV-Pax4-IRES-GFP.
The integration of each gene into the Ad was done by transfection into the Ad packing cell line 293 cells according to the manufacture's instructions. Ad titers were further increased up to 1!10 10 plaque forming units/ml with Vivapure AdenoPACK 100 purification kits (Vivascience, Edgewood, NY, USA).
Transduction of adenovirus to IHBECs
For transduction, media were changed to serum-free DMEM containing purified recombinant Ad -PDX-1, -NGN 3, -NEURO D, -PAX4 or -PDX-1/VP16 and incubated for 1 h at 37 8C. To test which multiplicity of infection (MOI) was most effective for transduction, IHBECs were infected at MOIs of 1, 10, 25, 50, 100 or 200 for 2 h at 37 8C. Two-days after transduction, cells were counted to determine the percentage of GFP C cells. Seven days after transduction, the cells were harvested and evaluated.
RNA isolation, cDNA synthesis, RT-PCR Total RNA was isolated from cultured cells at day 26 using RNeasy Mini Kits (Qiagen) according to manufacturersuggested protocols, and RT-PCR were conducted. The extracted total RNA was reverse-transcribed into cDNA with Omniscript RT Kit (Qiagen) using standard procedures. The primers were complementary to the mRNA sequences of the genes of interest and are listed in Supplementary Table 1, see Supplementary data in the online version of the Journal of Endocrinology at http://joe.endocrinology-journals.org/ content/vol201/issue1/. All the primers were designed to cross exon-exon boundaries to exclude the possibility that genomic DNA was amplified. The exception was MafA that lacks an intron. Twenty nanograms cDNA were applied to each well. PCR was performed with the following parameters: 36 cycles of 30 s at 94 8C, 90 s at 60 8C, 90 s at 72 8C.
Cell sorting
All samples were analyzed on an ARIA cell sorter with the Summit software (BD). The cells were dispersed to mostly single cells. Propidium iodide (PI, Sigma) was used for exclusion of dead cells; we gated both PI K GFP C /PI K GFP K populations to retrieve living cells from PDX-1/VP16 transduced cells. Both GFPC and GFPK single cells were placed into 96-well dishes. Group 1 and Group 2 cells were also dispersed into single cells and served as controls.
Analysis of single cells by RT-PCR
To detect our genes of interest from single cells, nested PCR was performed. Multiplex single-cell RT-PCR analysis was performed according to a previously described method with some modifications (Miyamoto et al. 2002) . Briefly, we first performed reverse-transcription followed by the first PCR. Sorted single cells were deposited into 96-well U-bottom plates (BD) with 7 . 5 ml lysis and RT buffer containing gene-specific reverse primers for Krt19, NeuroD, Pdx-1, Ins 1, Ins 2, Glucagon, Somatostatin, PP, and HPRT (Supplementary Table 1 ): the concentration of lysis buffer was the following: (1!First, Strand Buffer (Invitrogen), 10 mM dithiothreitol (Invitrogen), 1 mM dNTPs (New England BioLabs, Ipswich, MA, USA), 0 . 5% Triton X-100 (Sigma), 0 . 1% BSA, 10 U/ml M-MLV reverse transcriptase (Invitrogen), 0 . 1 U/ml RNase inhibitor (Invitrogen), 0 . 4 pM reverse primers). Retrieved cells were lysed by pipetting several times in the plate, and then cell lysates were transferred to 96-well optical Reaction Plate with Barcode (Applied Biosystem, Foster City, CA, USA). After incubation at 37 8C for 90 min, the samples were incubated at 94 8C for 30 s to inactivate the enzyme. This step is reverse-transcription and cDNAs are generated simultaneously. The first-round of PCR was carried out in the same plate by addition of premixed PCR buffer containing the gene-specific forward primers (1! GeneAmp PCR Gold Buffer (Applied Biosystem), 2 . 5 mM MgCl 2 , AmpliTaq Gold 0 . 1 U/ml, 0 . 1 pM forward primers).
The total volume of the first PCR reactions were 20 ml, and PCR was performed with the following parameters: 36 cycles of 30 s at 94 8C, 90 s at 60 8C, 90 s at 72 8C. For nested PCR, the second round PCR was performed as follows: 1 ml of the first-round PCR reactions were plated into new PCR plates, which contained mixed buffer (1!GeneAmp PCR Gold Buffer (Applied Biosystem), 2 . 5 mM MgCl 2 , AmpliTaq Gold (Applied Biosystem) 0 . 1 U/ml, and 0 . 25 pM forward primers). For the second-round PCR, each gene was analyzed separately using nested gene-specific primers with the following parameters: 35 cycles of 36 s at 94 8C, 90 s at 60 8C, 90 s at 72 8C. Aliquots of second-round PCR products were subjected to gel electrophoresis. Two hundred pg of total RNA isolated from mouse islets was used as a positive control.
Immunostaining
The methods used for immunostaining have been previously described . Briefly, cells on dishes were fixed in cold absolute ethanol after three rinses with PBS. Primary antibodies included mouse anti-cytokeratin 7 (1:25; CK7; Dako Cytomation), rabbit anti-cytokeratin 19 (1:1000; KRT19; a gift of Dr A Miyajima, Tokyo University, Japan), rabbit anti-NeuroD (1:200; Cell Signaling Technology, Inc., Danvers, MA, USA), rabbit anti-Pdx-1 (1:2000; IPF-1C antibody, a gift from Dr J M W Slack, University of Minnesota) and rabbit anti-C-peptide (1:400; Cell Signaling). Alexa 488 -conjugated and Alexa 594 -conjugated antibodies (Molecular Probes, Eugene, OR, USA) were used as secondary antibodies. Cell nuclei were counter-stained with PI (VECTASHIELD Mounting Medium with PI; Vector Laboratories, Ltd., Peterborough, England) or DAPI (VEC-TASHIELD Mounting Medium with DAPI). Cultures processed with secondary antibodies only were used as negative controls. Liver and pancreas sections were stained as positive controls.
Measurement of insulin production
Insulin levels in culture supernatants were measured using the ultrasensitive insulin ELISA (Crystal Chem, Inc, Downers Grove, IL, USA; detection limit of 0 . 04 ng/ml). Media from cultures from day 5 to day 7 after transduction were collected and measured as basal secretion. Subsequently, insulin secretion in response to secretagogues was measured, the cells were subjected to static incubation in Krebs-Ringer bicarbonate buffer (KRB; 133 mM NaCl, 4 . 69 mM KCl, 1 . 2 mM KH 2 PO 4 , 1 . 2 mM MgSO 4 , 25 mM HEPES, 2 . 52 mM CaCl, 2H 2 O, 5 mM NaHCO 3 ) supplemented with 5 mM glucose and 0 . 2% BSA. Plated in 12-well culture plates (BD), cells were washed four times with KRB. They were continuously incubated in KRB with low glucose (5 mM), high glucose (25 mM) or high glucose with 45 mM KCl for 2 h at 37 8C. Between each incubation, they were washed four times with KRB and incubated in KRB for 2 h. IHBECs (Group 1, nZ3), control cells (Group 2, nZ3), transduced cells (Group 3, the number of independent experiments with Pdx-1 was nZ6; NeuroD, nZ7; and Pdx-1/VP16, nZ7). Fold stimulation was calculated for each culture (1!10 5 cells/well per ml) by dividing the insulin concentration in the stimulation supernatant by the insulin concentration in the basal supernatant.
Statistical analysis
Experimental results were expressed as the meanGS.E.M. Student's t-test, ANOVA and Fisher's protected least significant difference test were used, and P!0 . 05 was considered significant. All experiments were repeated at least three times.
Results
Generation of insulin-producing cells from IHBECs
We have developed a five step-protocol for inducing the differentiation of IHBECs to insulin producing cells (Fig. 1) . In Step 1, the IHBEC-rich fraction was isolated from adult mouse liver with 1!10 5 viable cells/mouse being recovered, then in Step 2 their number was expanded with CEFCM. Figure 2A left and B left show macroscopic and phase contrast microscopic views respectively. After about 5 days with CEFCM, IHBECs formed three-dimensional ductal cysts (Fig. 2B, right) and rapidly expanded their number about
Step 1. Isolation of IHBEC-rich fraction from mouse (day 0).
Step 2. Isolated cells expanded with collagen-embedded floating culture method (CEFCM) (days 0-14).
Step 3. Seed IHBECs onto collagen culture dishes to make monolayers for 3 days in growth medium. (days 14-17)
Step 4. Media changed to serum-and insulin-free differentiation medium (DM); IHBECs cultured for an additional 2 days (days 17-19). Cells divided into three groups. Group 1 continued to be exposed to this condition.
Step 5. Differentiation manipulations. IHBECs transduced with adenoviral-mediated pancreatic transcription factors including Pdx-1, Neuro D-, Pdx-1/VP 16-GFP (Group 3) or GFP (Group 2) (days 19-26).
Step 6. Evaluation of the IHBECs phenotype. Step 2
Step 2
Step 3
Step 4
Step 5
Step 5 (control vector)
Day 17 Day 19 Day 26 Figure 1 General outline of the culture system and protocols for inducing the differentiation of IHBECs.
15-fold within 2 weeks (Fig. 2E) . The CG containing the expanding cells gradually shrank over 14 days (Fig. 2D) . In cultures without CEFCM (CEFCM-), IHBECs initially expanded but then started to die at around 8 days (Fig. 2E) . Initial experiments with IHBECs were performed to determine their behavior in tissue culture and their potential for transdifferentiation. RT-PCR and immunofluorescent staining were carried out with hepatocyte, biliary epithelial cell (BEC), and islet markers. Cells at day 0 expressed BEC markers but neither hepatocyte nor islet markers (Fig. 2F) . In addition, IHBECs expressed a number of hepatocyte nuclear factor (HNF) family genes, (HNF1b, HNF3b, HNF4a, HNF6) considered to be endoderm progenitor markers (Lemaigre & Zaret 2004 ). The cells were also positive for both CK7 (blue; Fig. 2G ) and KRT19 (data not shown).
At day 14, dispersed IHBECs were seeded onto collagencoated dishes and cultured for 3 more days (Step 3). These
IHBECs formed colonies and expanded about 2 . 4-fold during these 3 days. At day 17, cultured IHBECs without CEFCM displayed signs of senescence (large, multinucleated flat cells; Fig. 3A , black arrows) or numerous cytoplasmic vacuoles (Fig. 3A, white arrow heads) . IHBECs subjected to CEFCM culture had fewer senescent cells or cytoplasmic vacuoles (Fig. 3B) . These monolayers of homogenous appearing cells maintained their BEC character even at day 17 (Fig. 2F ) and proliferated efficiently in culture (Fig. 2G,  right) . The purity of IHBECS averaged O90% at day 17 as assessed by immunostaining for CK7 and KRT19.
For
Step 4, the media was changed to DM and the IHBECs were cultured for an additional 2 days. We focused first on generating insulin-expressing cells by testing soluble factors including activins, exendin-4, HGF, IGFs, nicotinamide, and betacellulin. After seven additional days (Step 5) in DM Control (Group 1), IHBECs started to express staining for cytokeratin 7. RT-PCR was carried out to clarify the character of IHBECs at day 0 and day 17. Hepatocyte markers (tryptophan oxygenase (TO), tyrosine aminotransferase (TAT), cytochrome P450 1A2 (CYP1A2)), BEC markers (Cytokeratin (CK)7 and 19, g-glutamyltranspeptidase (g-GTP), islet markers (Insulin 1, Glucagon, Somatostatin, and Pancreatic polypeptide (PP)), and what are considered to be endoderm progenitor markers (HNFs1b, 3b, 4a, and 6). The oligonucleotide primers and cycle number used for semiquantitative PCR are shown in Supplementary Table 1 . Mouse liver and islets were used as controls. Gene expression studies in all groups were repeated at least three times independently. (G) Immunofluorescent analysis for CK7 in IHBECs. IHBECs were positive for both for CK7 (blue) at days 0 (G, left) and 17 (G, right). Propidium iodide (PI, red) was used to show nuclei. Scale bar, 100 mm.
some endocrine progenitor genes (Ngn 3, NeuroD, Nkx6.1 and Pdx-1), but lacked Ins mRNA (Fig. 5A) . Therefore, we decided to transduce the IHBECs with Ad-Pdx-1, -Neurog3, -Neuro D, -Pax4 and -Pdx-1/VP16. 
Gene expression profiles of IHBECs-derived insulin-producing cells
To analyze the molecular events occurring in IHBECs during the series of culture steps, gene expression profiles of transcription factors and pancreas-related genes were determined by RT-PCR. IHBECs at Step 1 only expressed BEC markers and early liver and pancreas markers (Fig. 2F) . At the end of Step 4, Group 1 cells expressed the pancreatic progenitor markers Neurog3, NeuroD, Nkx6.1, Pdx-1, and pancreas-specific transcription factor 1a (Ptf1a; Fig. 4A ). These genes were not observed in cultured IHBECs at day14, therefore, the IHBECs assumed these characteristics in DM culture. Transduced expression of Pdx-1, NeuroD or Pdx-1/ VP16 led to expression of not only both Ins 1 and 2 but also Glut2 and prohormone convertases 1 and 2 (PC1 and 2).
Glucokinase was also expressed at this stage (data not shown).
Pdx-1 or Pdx-1/VP16 transduced cells faintly expressed amylase (Fig. 4A) . Expression of Ptf1a was found in all groups. Neither Ad-NEUROG3 nor Ad -PAX4 led to express Ins, therefore, their use were discontinued.
Immunostaining of IHBECs 7 days after transduction with Ad-Pdx-1/VP16
PDX-1/VP16 transduction led to the appearance of endocrine precursor and islet related markers. Using immunofluorescence analysis, cells stained for NEUROD C (nuclear) co-expressed both GFP and CK7 (cytoplasm; Fig. 5A ). There was complete overlap of NEUROD and DAPI in the nuclei (Fig. 5B) . A relatively small number of NEUROD C GFP K cells were seen (data not shown). Cells with nuclear Pdx-1 staining also co-expressed GFP and CK7 (Fig. 5C ). As expected, due to the Pdx1/VP16 transduction the number of Pdx-1 C cells was larger than that of NEUROD C cells (Fig. 5C ). C-peptide staining confirmed the synthesis of insulin by IHBECs-derived insulin-producing cells. We found that 30 . 1 and 2 . 8% of 4000 cells counted in Pdx-1/VP16 transduced cultures were GFP C and C-peptide C respectively ( Fig. 5E and F) . Of the GFPC cells, about 6% were strongly stained for C-peptide.
Insulin release into the culture medium by clusters of IHBECs-derived insulin-producing cells
Insulin release into the culture medium was measured at 7 days after transduction (Fig. 5G) . From day 5 to day 7 after transduction, Ad-Pdx-1, NeuroD, and Pdx-1/VP16 transduced IHBECs released insulin (Ad-Pdx-1 0 . 08G0 . 05, (Fig. 5G) .
We also monitored the release of insulin into the culture medium in response to various stimuli supplied sequentially over 2 h intervals for group 3 cells. No basal insulin release could be detected for any of the transduced cells, but after exposure to 25 mM glucose or 45 mM KCl, barely measurable amounts of insulin from Pdx-1/VP16 transduced cells were found in a small number for experiments. Little can be concluded from these inconsistent results. Questions could be raised about, whether 25 mM glucose is high enough to have a glucose toxicity effect. Because such a concentration has been used successfully so often in other studies, we doubt this type of toxicity is contributing much to the low secretion.
Characterization of transduced IHBECs with single cell PCR
From the previous results, it was clear that some IHBECs transduced with PDX-1, NEURO D, PDX-1/VP16 produced insulin. We therefore attempted to characterize these cells on a single cell level. GFPC and GFPK single cells from PDX-1/VP16 transductions were placed into wells of 96-well dishes by the ARIA sorter. We gated both PI K GFP C populations to retrieve only living cells (Fig. 6B) . Group 1 cells were also dispersed into single cells and used as controls (Fig. 6A ). Both PI K GFP C populations from Group 2 were also analyzed by the same manner. Twenty three percent of GFP C cells expressed both the insulin 1 and 2 genes in Ad-PDX-1/VP16 transduced IHBECs; cells always expressed both or neither insulin genes. These Ins 1 and 2 expressing cells also expressed endogenous NeuroD and Pdx-1 genes (data not shown). Importantly, these cells expressed other marker genes including islet genes (Glucagon, Somatostatin, and Ppy) and KRT19 (Table 1C) . Neither cells in control group 1 nor GFP negative cells in PDX-1/VP16 transduced cells exhibited insulin gene expression (Table 1A and B). Cells in group 2 were similar to the result of group 1. Twenty eight percent of cells from group 2 expressed Pdx-1, however, they lacked Ins gene expression.
Discussion
We characterized the differentiation process of transduced IHBECs at the RNA level using RT-PCR, and at protein levels with immunofluorescence and ELISA. To convincingly show that IHBECs produced insulin, exogenous insulin was eliminated from step 4 because apoptotic cells can take up exogenous insulin from the culture medium (Rajagopal et al. 2003) . We found both insulin mRNA as well as de novo synthesis of C-peptide by immunocytochemistry. We have not yet determined the relative proportions of proinsulin to Figure 4 Gene expression profiles in each group. b-cell related markers (Insulin 1 and 2, glucagon, somatostatin, and pancreatic polypeptide, prohormone convertase (PC 1 and 2), Glucose transporter 2 (GLUT2)), transcription factors (Neurogenin3 (NEUROG3), NeuroD, Nkx2.2, Paired box4 (Pax4), Nkx6.1, MafA, Pdx-1, and Islet-1 (Isl1)), exocrine cell related markers (pancreas-specific transcription factor 1a (Ptf1a), Amylase) and b-actin mRNA transcripts were assessed. IHBECs at day 14 in culture were used as a control. Mouse islets, insulinoma cell line MIN6, pancreas were controls. Findings are representative of at least three independent experiments for each. The oligonucleotide primers and cycle number used for semiquantitative PCR are shown in Supplementary Table 1 .
insulin, but expect that full processing has not taken place in these cells that are not fully differentiated. Our findings demonstrated that IHBECs can be transdifferentiated to insulin-producing cells. The transcription factors HNF1b, HNF3b, HNF4a, HNF6 are islet progenitor markers (Wilson et al. 2003) , which form a transcriptional network that coordinates b-cell development and function (Rausa et al. 1997 , Sumazaki et al. 2004 , Zaret 2008 . Even though HNF1b in such cells is downstream of HNF6, it has a crucial role for BECs development (Clotman et al. 2002 , Lemaigre & Zaret 2004 . Moreover, the expression of HNF1b to define a cellular population that forms the primitive pancreatic ducts (Rausa et al. 1997) . Such embryonic duct HNF1b C cells are phenotypically distinct from earlier pancreatic bud cells, and evidence suggests that they are direct precursors of the NEUROG3 C endocrine progenitor cells required for endocrine cell formation ( Jacquemin et al. 2000 , Xu et al. 2008 . We found that IHBECs even at an early stage possessed these important initiation transcripts (Fig. 2) and that Neurog3 gene was induced in IHBECs at step 4 even without molecular engineering.
Even though IHBECs are attractive targets for transdifferentiation, the previous techniques for isolation of IHBECs have been cumbersome and associated with a low yield of cells (Alvaro et al. 1993 , Alpini et al. 1997 . Furthermore, in vitro studies with freshly isolated cells or intrahepatic bile duct units fragments are limited by the lack of long-term (O24 h) viability (Alpini et al. 2003) . Therefore, expansion to obtain significant quantities of healthy IHBECs was an important goal. We thought that maintenance of the polarized characteristics of biliary epithelium might facilitate that goal and postulated that a three-dimensional matrix might be helpful. It has been found that three-dimensional culture conditions can allow polarized cells to keep their original character (Grünert et al. 2003 , Matsuoka et al. 2006 . As indicated in Fig. 2E , many cells died within 2 weeks when cultured in two-dimensional conditions. Because the media with its growth factors and collagen were the same with two dimensions versus three-dimensional cultures, we assume there is some effect of the three-dimensional geometry that promoted expansion and improved viability.
From step 4, our serum-and insulin-free DM was used in hopes of priming the cells for transdifferentiation. Indeed, these cells began to express the pancreatic progenitor markers M NAGAYA and others . IHBECs induced in vitro to become insulin-producing cells NEUROD, NEUROG3, NKX6.1, PDX-1, and PTF1a (Fig. 4A) . If the cells were exposed to GM at this stage, they proliferated and did not express these transcripts (data not shown). Work by Gershengorn et al. (2004) showed that to induce insulin mRNA in cytokeratin positive cells, elimination of EGF and the use serum free medium was important.
During stage 4 in DM culture, markers for both pancreatic epithelial progenitors and endocrine precursors were found. Recent reports find that Ptf1a is expressed in the progenitors of pancreatic ducts, exocrine, and endocrine cells, rather than being an exocrine-specific gene as previously thought (Kawaguchi et al. 2002) . Thus, co-expression of PTF1a and PDX-1 is required for proper pancreatic determination and subsequent differentiation (Kawaguchi et al. 2002 , Afelik et al. 2006 , Wiebe et al. 2007 . IHBECs cultured for 14 days did not express PTF1a; however, all groups of cells expressed PTF1a after DM culture. It is possible that expression of PTF1a is a prerequisite for transdifferentiation. The combined use of a two-dimensional culture environment and DM accerelated differentiation pathways toward pancreatic fate but failed to induce insulin gene expression (Fig. 4A) . Seven days after transduction with Ad-PDX-1, NEUROD, or PDX-1/VP16, insulin expression was found by RT-PCR, immunofluorescence and ELISA. To further characterize these cells, we examined islet hormone gene expression in single cells that had been transduced with PDX-1/VP16 and found that 91% of Ins1 and 2 positive single cells expressed all four islet hormone genes (Table 1 ). This expression of multiple islet hormones likely reflects immaturity as previous studies have found that islet cells can express more than one of these islet hormones simultaneously (Alpert et al. 1988 , De Krijger et al. 1992 , Teitelman et al. 1993 . It is clear that some of these transduced cells have insulin gene expression and contain insulin protein.
We can be confident that this insulin resulted from biosynthesis rather than uptake from the medium, as judged by the following criteria: 1) no insulin was detected in GFP transduced IHBECs in the same conditions, 2) insulin was detected in transduced IHBECs in DM that was not 
) Number/% 100 (100) 94 (94) 23 (23) 21 (21) 21 (21) 21 (21) supplemented with insulin, 3) both Ins1 and 2 mRNA were detected in the cells 4) C-peptide was detected in the cells by immunofluorescence. There are differences among the cells that express insulin, which likely reflects variation in differentiation. Thus, about 23% of GFPC cells Pdx-1/ VP16 transduced cells express Insulin by nested PCR. Of these GFPC cells, about 6% were strongly stained for C-peptide. We were unable to demonstrate glucose-induced secretion from transduced cells, but future in vitro and in vivo experiments will determine the capacity of these cells for further differentiation. Data are only presented from the experimental conditions described in the methods. We have also used various doses and combinations of other agents including nicotinamide, betacellulin, activins, hepatocyte growth factor, and exendin-4, but these efforts have not provided improved results. Work on finding optimal differentiation conditions is continuing.
In summary, it has been possible to force the differentiation of IHBECs towards a b-cell phenotype, which supports the possibility that these cells have the potential to be useful for b-cell replacement therapy.
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